Do Erythropoiesis-Stimulating Agents (ESAs) Affect Survival in Anemic Patients with Myelodysplastic Syndromes (MDS)? Davidoff, A. J., Ke, X., Baer, M. R., Smith, S., Zandberg, D., Hendrick, F., Sato, M., Greenberg, P. L., Gore, S. D. AMER SOC HEMATOLOGY. 2011: 1204–5

View details for Web of Science ID 000299597104145